Has Dakshin Gangadharamurthy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,150 in general payments to Dakshin Gangadharamurthy, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dakshin Gangadharamurthy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dakshin Gangadharamurthy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dakshin Gangadharamurthy, MD

Cardiovascular Disease · Washington Township, OHNPI 1609005578

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,001 of the $1,150 with a category attached, or 87.1%. 11 manufacturers reported payments, led by Abbott at 24.4% of the total. Reporting peaked in 2020 at $530 and has fallen 96.6% since, to $18 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in OH, where the typical reported total is $1,347.

$1,150in general payments, 2019–2025

Across 45 payments — averaging $25.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$280
AstraZeneca$271
Boston Scientific$148
Johnson & Johnson$148
Novartis$111
Pfizer$98
plus $94 from 5 others

What the payments were for

Food & beverage$1,00187%
Education$14813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	2	$280
AstraZeneca	13	$271
Boston Scientific	1	$148
Johnson & Johnson	10	$148
Novartis	7	$111
Pfizer	6	$98
Boehringer Ingelheim	2	$33
Daiichi Sankyo Inc.	1	$21
Akcea Therapeutics, Inc.	1	$18
Chiesi USA, Inc.	1	$11
Regeneron Healthcare Solutions, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,150 in reported general payments places this provider in the 45th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio →

Medicare billing

Part B allowed, 2024

$14,845

Medicare patients

215

Services billed

377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	14	$128

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Washington Township

Guilherme AttizzaniCleveland$1.3M
Gregory LamCircleville$428K
Emil HayekHudson$379K
Abraham LincoffCleveland$369K
Oussama WazniCleveland$367K
Ian NeelandCleveland$329K
Kamal ShemisaCincinnati$314K
Mehdi ShishehborElyria$237K
Abdu HawwaGarfield Hts$234K
Jayanta MukherjeeColumbus$227K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →